Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.78 - $3.64 $67,572 - $138,181
37,962 New
37,962 $75,000
Q2 2022

Aug 12, 2022

BUY
$3.27 - $8.76 $535,370 - $1.43 Million
163,722 New
163,722 $565,000
Q2 2021

Aug 12, 2021

SELL
$18.15 - $27.75 $164,003 - $250,749
-9,036 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$20.71 - $51.02 $187,135 - $461,016
9,036 New
9,036 $222,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $171M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.